Shin Nippon Biomedical Laboratories Clinical Pharmacology Center's Corporate Majority Round

Shin Nippon Biomedical Laboratories Clinical Pharmacology Center raised a round of funding on February 28, 2017. Investors include Pharmaron.

Shin Nippon Biomedical Laboratories Clinical Pharmacology Center, or SNBL CPC, specializes in Phase I-II trials, including TQT/Phase 1 QT de-risking, first-In-human (FIH), Japanese Bridging and Phase …

Articles about Shin Nippon Biomedical Laboratories Clinical Pharmacology Center's Corporate Majority Round: